Announcements

Announcements

 

Paul G. Allen Frontiers Group [to 25 Jan 2020]
https://alleninstitute.org/what-we-do/frontiers-group/news-press/
News
No new digest content identified.

 

BMGF – Gates Foundation [to 25 Jan 2020]
http://www.gatesfoundation.org/Media-Center/Press-Releases
JANUARY 21, 2020
Bill & Melinda Gates Foundation Statement on Creation of Nonprofit Agricultural Research Institute
SEATTLE, January 21, 2020 – The Bill & Melinda Gates Foundation is in the process of creating a new 501(c)(3) nonprofit, Bill & Melinda Gates Agricultural Innovations, LLC, which seeks to accelerate the development of innovations supported by the foundation’s Agricultural Development team. The entity, to be known as Gates Ag One, aims to speed up efforts to provide smallholder farmers in developing countries, many of whom are women, with access to the affordable tools and innovations they need to sustainably improve crop productivity and adapt to the effects of climate change.

 

Bill & Melinda Gates Medical Research Institute [to 25 Jan 2020]
https://www.gatesmri.org/
The Bill & Melinda Gates Medical Research Institute is a non-profit biotech organization. Our mission is to develop products to fight malaria, tuberculosis, and diarrheal diseases—three major causes of mortality, poverty, and inequality in developing countries. The world has unprecedented scientific tools at its disposal; now is the time to use them to save the lives of the world’s poorest people
No new digest content identified.

 

CARB-X [to 25 Jan 2020]
https://carb-x.org/
CARB-X is a non-profit public-private partnership dedicated to accelerating antibacterial research to tackle the global rising threat of drug-resistant bacteria.
No new digest content identified.

 

CEPI – Coalition for Epidemic Preparedness Innovations [to 25 Jan 2020]
http://cepi.net/
Latest news
CEPI to fund three programmes to develop vaccines against the novel coronavirus, nCoV-2019
23 Jan 2020
[See Milestones above for detail]

 

Clinton Health Access Initiative, Inc. (CHAI) [to 25 Jan 2020]
https://clintonhealthaccess.org/
News & Press Releases
No new digest content identified.

 

EDCTP [to 25 Jan 2020]
http://www.edctp.org/
The European & Developing Countries Clinical Trials Partnership (EDCTP) aims to accelerate the development of new or improved drugs, vaccines, microbicides and diagnostics against HIV/AIDS, tuberculosis and malaria as well as other poverty-related and neglected infectious diseases in sub-Saharan Africa, with a focus on phase II and III clinical trials
Latest news
No new digest content identified.

 

Emory Vaccine Center [to 25 Jan 2020]
http://www.vaccines.emory.edu/
No new digest content identified.

 

European Medicines Agency [to 25 Jan 2020]
http://www.ema.europa.eu/ema/
News & Press Releases
News: Martina Schüssler-Lenz re-elected as chair of Committee for Advanced Therapies
Last updated: 24/01/2020

 

 

Press release: Ten recommendations to unlock the potential of big data for public health in the EU
Last updated: 20/01/2020
Ten recommendations to unlock the potential of big data for public health in the EU (PDF/175.06 KB) (new) First published: 20/01/2020 EMA/689902/2019

 

European Vaccine Initiative [to 25 Jan 2020]
http://www.euvaccine.eu/news-events
No new digest content identified.

 

FDA [to 25 Jan 2020]
https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/default.htm
Press Announcements
No new digest content identified.

 

Fondation Merieux [to 25 Jan 2020]
http://www.fondation-merieux.org/
News, Events
No new digest content identified.

 

Gavi [to 25 Jan 2020]
https://www.gavi.org/
24 January 2020
Gavi statement following the death of Peter Salama

23 January 2020
World leaders commit to Gavi’s vision to protect the next generation with vaccines
As Gavi celebrates its 20th anniversary at Davos, Germany and the Bill & Melinda Gates Foundation pledged catalytic support to Gavi, citing remarkable progress since 2000
Davos, 23 January 2020 – Global leaders committed to Gavi, the Vaccine Alliance’s vision to immunise hundreds of millions of children in the world’s poorest countries as they celebrated Gavi’s 20th anniversary at the World Economic Forum (WEF), citing remarkable progress since its inception in 2000.
Demonstrating outstanding leadership in global health, Chancellor Angela Merkel announced at WEF that Germany will commit €600 million for the 2021-25 five-year period…
The Bill & Melinda Gates Foundation also announced on the sidelines of the World Economic Forum in Davos that it will renew its US$ 75 million contribution to the Gavi Matching Fund, an innovative public-private funding mechanism that secures resources to incentivise private sector investments in immunisation…

 

GHIT Fund [to 25 Jan 2020]
https://www.ghitfund.org/newsroom/press
GHIT was set up in 2012 with the aim of developing new tools to tackle infectious diseases that No new digest content identified.

 

Global Fund [to 25 Jan 2020]
https://www.theglobalfund.org/en/news/
News & Stories
News
Global Fund Appoints New Head of Technical Advice & Partnerships
24 January 2020
GENEVA – The Global Fund to Fight AIDS, Tuberculosis and Malaria today announced the appointment of Michael Byrne as Head of the Technical Advice & Partnerships Department as the Global Fund strengthens technical expertise in disease teams.
“To step up the fight and most effectively leverage additional funds, we are elevating the capacity of our disease teams to help achieve global targets,” said Peter Sands, Executive Director of the Global Fund. “Michael will lead these efforts, and they should make a significant difference in our work with partners to accelerate progress against HIV, TB and malaria.”
Byrne brings 30 years of experience in international development including 13 years at the Global Fund…

News
Global Fund Grant in the Democratic People’s Republic of Korea
23 January 2020
The Global Fund has reached agreement with partners for a consolidated grant for tuberculosis and malaria in the Democratic People’s Republic of Korea, and implementation of the grant has begun.
Under this grant, the drug-susceptible tuberculosis and malaria component will be implemented by UNICEF and the World Health Organization. The multidrug-resistant tuberculosis (MDR-TB) component will be implemented by the Eugene Bell Foundation. With these revised implementation arrangements, the Global Fund is confident that partners can serve more people affected by tuberculosis and malaria, and achieve required levels of assurance that the grant is being implemented effectively.
The agreement was made possible by extensive collaboration by technical and development partners, and by the Government of DPRK. The Global Fund remains committed to supporting the health of people in DPRK, and thanks all partners for their continuous cooperation and collaboration during the grant negotiations.

Voices
Ending Tuberculosis is Good for Business – New Initiative Launched to End Tuberculosis in the Workplace
22 January 2020

 

Hilleman Laboratories [to 25 Jan 2020]
http://www.hillemanlabs.org/
News
No new digest content identified.

 

Human Vaccines Project [to 25 Jan 2020]
http://www.humanvaccinesproject.org/media/press-releases/
Press Releases
No new digest content identified.

 

IAVI [to 25 Jan 2020]
https://www.iavi.org/newsroom
No new digest content identified.

 

 

International Coalition of Medicines Regulatory Authorities [ICMRA]
http://www.icmra.info/drupal/en/news
Selected Statements, Press Releases, Research
No new digest content identified.

 

 

International Generic and Biosimilar Medicines Association [IGBA]
https://www.igbamedicines.org/
News
No new digest content identified.

 

 

IFFIm
http://www.iffim.org/
No new digest content identified.

 

IFRC [to 25 Jan 2020]
http://media.ifrc.org/ifrc/news/press-releases/
Selected Press Releases, Announcements
No new digest content identified.

 

IVAC [to 25 Jan 2020]
https://www.jhsph.edu/research/centers-and-institutes/ivac/index.html
Updates
No new digest content identified.

 

IVI [to 25 Jan 2020]
http://www.ivi.int/
Selected IVI News & Announcements
No new digest content identified.

 

JEE Alliance [to 25 Jan 2020]
https://www.jeealliance.org/
Selected News and Events
No new digest content identified.

 

MSF/Médecins Sans Frontières [to 25 Jan 2020]
http://www.msf.org/
Latest [Selected Announcements]
Greece
Greece denies healthcare to seriously ill refugee children on Lesbos
Press Release 23 Jan 2020

Access to medicines
Our 2020 wishlist – five New Year’s resolutions for medical care
Campaign 22 Jan 2020

Access to medicines
Gavi must ensure more children get new, more affordable pneumonia vaccine
Press Release 21 Jan 2020
:: A new vaccine against one of the world’s deadliest childhood diseases – pneumonia – is now available at a more affordable price than existing vaccines.
:: Vaccine funding organisation, Gavi, the Vaccine Alliance, has a $1.5 billion funding programme for the pneumonia vaccine, of which 80 per cent has already been paid to two pharma giants.
:: MSF urges Gavi – and WHO, UNICEF and the Gates Foundation – to ensure that the remaining amount is spent to ensure access to this third, more affordable, vaccine to protect children.

 

National Vaccine Program Office – U.S. HHS [to 25 Jan 2020]
https://www.hhs.gov/vaccines/about/index.html
NVAC 2020 Meetings
February 13-14, 2020 NVAC Meeting
June 9-10, 2020 NVAC Meeting
September 23-24, 2020 Meeting (Virtual)

Update
The Fight Against Cervical Cancer Starts with HPV Vaccination

 

NIH [to 25 Jan 2020]
http://www.nih.gov/news-events/news-releases
Selected News Releases
NIH officials discuss novel coronavirus that recently emerged in China
January 23, 2020 — Research underway to address latest viral threat:
CI Paules et al. Coronavirus infections: More than just the common cold. Journal of the American Medical Association. DOI: 10.1001/jama.2020.0757 (2020).

 

PATH [to 25 Jan 2020]
https://www.path.org/media-center/
Selected Announcements
No new digest content identified.

 

Sabin Vaccine Institute [to 25 Jan 2020]
http://www.sabin.org/updates/pressreleases
Statements and Press Releases
No new digest content identified.

 

UNAIDS [to 25 Jan 2020]
http://www.unaids.org/en
Selected Press Releases/Reports/Statements
23 January 2020
Empowering young people living with HIV to became agents of change in Thailand

20 January 2020
Supporting communities to be involved in the AIDS response in Thailand

20 January 2020
Cash transfer schemes reduce the chances of adolescent girls and young women contracting HIV
Efforts aimed at redressing gender inequalities and socioeconomic inequities can mitigate factors that fuel the HIV epidemic.
In a study in Eswatini, cash transfers aimed at keeping adolescent girls and young women in school and giving them greater financial independence resulted in the odds of the recipients becoming HIV-positive being 25% lower than for people who were not eligible for the incentive.
Studies from Eswatini, Lesotho, Malawi and the United Republic of Tanzania show that cash transfers help young people, especially girls, stay in school longer and do better in their studies. Other evidence indicates that cash grants that enable girls to continue their schooling also delay their sexual debut, increase their use of health services, reduce teen pregnancies and early marriage, and can promote safer sexual behaviours.

 

UNICEF [to 25 Jan 2020]
https://www.unicef.org/media/press-releases
Selected Statements, Press Releases, Reports
Press release
UNICEF mourns death of Dr. Peter Salama
Statement by Henrietta Fore, UNICEF Executive Director
24/01/2020

Press release
On World Education Day, UNICEF unveils latest innovation to improve education in emergencies: The High Performance Tent
23/01/2020

Press release
1 in 3 adolescent girls from the poorest households has never been to school
As the World Economic Forum Annual Meeting begins tomorrow and education ministers convene at the Education World Forum today, UNICEF urges policy-makers to address ‘shameful’ disparities in public education spending
19/01/2020

 

Vaccination Acceptance Research Network (VARN) [to 25 Jan 2020]
https://vaccineacceptance.org/news.html#header1-2r
No new digest content identified.

 

Vaccine Confidence Project [to 25 Jan 2020]
http://www.vaccineconfidence.org/
[Undated]
The European Regional Office of the Vaccine Confidence Project™
Professor Heidi Larson has recently joined the Centre for the Evaluation of Vaccination (CEV), University of Antwerp, as associate professor, as the CEV at the Antwerp University will host the European Regional Office of the Vaccine Confidence Project™ as of May 15, 2019, and will closely collaborate with Vaccine Confidence Project partners at European level on implementing the Vaccine Confidence Index™ and developing and evaluating interventions to address vaccine hesitancy.

 

Vaccine Education Center – Children’s Hospital of Philadelphia [to 25 Jan 2020]
http://www.chop.edu/centers-programs/vaccine-education-center
Newsletter – January 2020
Announcements: December webinar archived

 

Wellcome Trust [to 25 Jan 2020]
https://wellcome.ac.uk/news
No new digest content identified.

 

The Wistar Institute [to 25 Jan 2020]
https://www.wistar.org/news/press-releases
Press Release
Jan. 24, 2020
TP53 Genetic Variant Found in Individuals of African Descent is Linked to Iron Overload but May Improve Response to Malaria
Iron accumulation and defects in the antibacterial function of macrophages caused by the P47S variant result in a less severe inflammatory response.

Press Release
Jan. 23, 2020
Wistar Joins Global Effort to Expedite Coronavirus Vaccine Development for Outbreak Originating in China
Coalition for Epidemic Preparedness Innovations Supports DNA Vaccine Based on Key Wistar Technology.
[See detail under Coronavirus above]

 

World Organisation for Animal Health (OIE) [to 25 Jan 2020]
https://www.oie.int/en/for-the-media/press-releases/2020/
No new digest content identified.

 

 

::::::

 

ARM [Alliance for Regenerative Medicine] [to 25 Jan 2020]
https://alliancerm.org/press-releases/
No new digest content identified.

 

BIO [to 25 Jan 2020]
https://www.bio.org/press-releases
Press Releases
No new digest content identified.

 

DCVMN – Developing Country Vaccine Manufacturers Network [to 25 Jan 2020]
http://www.dcvmn.org/
News
No new digest content identified.

 

IFPMA [to 25 Jan 2020]
http://www.ifpma.org/resources/news-releases/
Selected Press Releases, Statements, Publications
No new digest content identified.

 

PhRMA [to 25 Jan 2020]
http://www.phrma.org/
Selected Press Releases, Statements
No new digest content identified.

 

Industry Watch [to 25 Jan 2020]
:: Pfizer Vaccines Launches Global Centers of Excellence Network to Conduct Real-World Research on Vaccine-Preventable Diseases Affecting Adults
University of Louisville Named First Center of Excellence
January 23, 2020
NEW YORK–(BUSINESS WIRE)–Pfizer Inc. (NYSE: PFE) announced today the launch of its Vaccines Division’s Centers of Excellence Network, a global program of collaborations with academic institutions to conduct real-world epidemiologic research to accurately identify and measure the burden of specific vaccine-preventable diseases and potentially evaluate vaccine effectiveness affecting adults. Pfizer Vaccines has designated the University of Louisville as its first Center of Excellence with a second global center anticipated in the first half of 2020.
“The Centers of Excellence will complete comprehensive, disease surveillance and real-world vaccine effectiveness studies, which are distinctly different from clinical safety and efficacy research,” said Luis Jodar, Pfizer Vaccines, Chief Medical and Scientific Affairs Officer. “With strategically located research centers around the world, we anticipate being able to better define and understand global disease burden in adults and vaccine effectiveness, which will help provide robust evidence to national policymakers and health officials who develop recommendations for the use of vaccines in immunization programs worldwide.”
As Pfizer’s first Center of Excellence site, the University of Louisville will initially conduct two separate, large population-based epidemiological studies in adults: a one-year study of the incidence of infectious diarrhea with funding provided by Pfizer up to $6.5 million and a one-year study of the incidence of pneumonia with funding provided by Pfizer up to $4.5 million…

:: Moderna Announces Funding Award from CEPI to Accelerate Development of Messenger RNA (mRNA) Vaccine Against Novel Coronavirus
Collaboration includes the National Institutes of Health (NIH) and leverages flexibility of Moderna’s mRNA vaccine technology
January 23, 2020

:: Inovio Selected by CEPI to Develop Vaccine Against New Coronavirus Jan 23, 2020